Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: Implications for neurodevelopmental models of schizophrenia

Psychopharmacology

Volumn 169, Issue 3-4, 2003, Pages 298-307

  Zuckerman, L ^a   Rimmerman, N ^a   Weiner, I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amphetamine; Clozapine; Development; Latent inhibition; M100907; Periadolescence; Schizophrenia

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; AMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMOTION; EXPOSURE; FOLLOW UP; LATENT INHIBITION; LOCOMOTION; MALE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PUBERTY; RAT; SCHIZOPHRENIA; SHOCK; STATISTICAL SIGNIFICANCE; THIRST;

AGING; AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CLOZAPINE; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; DRINKING BEHAVIOR; FLUOROBENZENES; MALE; MODELS, NEUROLOGICAL; MOVEMENT; NEURAL INHIBITION; PIPERIDINES; RATS; RATS, WISTAR; SCHIZOPHRENIA; TIME FACTORS;

EID: 0141958837     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1460-8     Document Type: Article

References (69)

1. Al-Amin HA, Shannon Weickert C, Weinberger DR, Lipska BK (2001) Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 49:528-539
2. Andersen SL, LeBlanc CJ, Lyss PJ (2001) Maturational increases in c-fos expression in the ascending dopamine systems. Synapse 41:345-350
3. Arnold SE (1999) Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev Psychopathol 11:439-456
4. Barkley RA (1977) A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 18:137-165
5. Bolanos CA, Glatt SJ, Jackson D (1998) Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev Brain Res 111:25-33
6. Bouton ME (1993) Context, time, and memory retrieval in the interference paradigms in Pavlovian learning. Psychol Bull 114:80-99
7. Campbell JO, Wood RD, Spear LP (2000) Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiol Behav 68:487-493
8. Cirulli F, Laviola G (2000) Paradoxical effects of d-amphetamine in infant and adolescent mice: role of gender and environmental risk factors. Neurosci Biobehav Rev 24:73-84
9. Ellenbroek BA, Cools AR (1995) Maternal separation reduces latent inhibition in the conditioned taste aversion paradigm. Neurosci Res Commun 17:27-33
10. Ellison G (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev 20:250-267
11. Franchina JJ, Domato GC, Patsiokas AT, Griesemer HA (1980) Effects of number of pre-exposures on sucrose taste aversion in weanling rats. Dev Psychobiol 13:25-31
12. Frantz K, Van Hartesveldt C (1999a) Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects. Eur J Pharmacol 369:145-157
13. Frantz K, Van Hartesveldt C (1999b) The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats. Eur J Pharmacol 368:125-135
14. Gaisler-Salomon I, Weiner I (2003) Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology 166:333-342
15. Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14:1-84
16. Gray JA, Moran PM, Grigorian G, Peters SL, Young AMJ, Joseph MH (1997) Latent inhibition: The nucleus accumbens connection revisited. Behav Brain Res 88:27-34
17. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B (1999) Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20:525-532
18. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593-624
19. Hoffmann H, Spear NE (1989) Facilitation and impairment of conditioning in the preweanling rat after prior exposure to the conditioned stimulus. Anim Learn Behav 17:63-69
20. Holt W, Maren S (1999) Muscimol inactivation of the dorsal hippocampus impairs contextual retrieval of fear memory. J Neurosci 19:9054-9062
21. Honey RC, Good M (1993) Selective hippocampal lesions abolish the contextual specificity of latent inhibition and conditioning. Behav Neurosci 107:23-33
22. Infurna RN, Spear LP (1979) Developmental changes in amphetamine-induced taste aversions. Pharmacol Biochem Behav 11:31-35
23. Joseph MH, Peters SL, Moran PM, Grigoryan GA, Young AM, Gray JA (2000) Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience 101:921-930
24. Killcross AS, Robbins TW (1993) Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology 110:479-489
25. Killcross AS, Dickinson A, Robbins TW (1994a) Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology 115:185-195
26. Killcross AS, Dickinson A, Robbins TW (1994b) Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: Evidence for dopamine-reinforcer interactions. Psychopharmacology 115:196-205
27. Laviola G, Adriani W, Terranova ML, Gerra G (1999) Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23:993-1010
28. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 50:884-897
29. Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23:223-39
30. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage - a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75
31. Lubow RE, Gewirtz JC (1995) Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull 117:87-103
32. McAllister KH (1997) A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibition. Psychopharmacology 130:79-84
33. Moser PC, Moran PM, Frank RA, Kehne JH (1996) Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behav Brain Res 73:163-167
34. Moser PC, Hitchcock JM, Lister S, Moran PM (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Rev 33:275-307
35. Ney PG (1967) Psychosis in a child, associated with amphetamine administration. Can Med Assoc J 97:1026-1029
36. Nicolle MM, Barry CC, Veronesi B, Stanton EM (1994) Fornix transections disrupt the ontogeny of latent inhibition in the rat. Psychobiology 17:349-357
37. Oades RD (1985) The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci Biobehav Rev 9:261-282
38. Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatric Res 33:523-533
39. Robbins TW, Sahakian BJ (1983) Behavioural effects of psychomotor stimulant drugs: clinical and neuropsychological implications. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 301-338
40. Rudy JW (1994) Ontogeny of context-specific latent inhibition of conditioned fear: implications for configural associations theory and hippocampal formation development. Dev Psychobiol 27:367-379
41. Schmajuk NA, Cox L, Gray JA (2001) Nucleus accumbens, entorhinal cortex and latent inhibition: A neural network model. Behav Brain Res 118:123-141
42. Shadach E, Feldon J, Weiner I (1999) Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. Int J Neuropsychopharmacology 4:283-291
43. Shadach E, Gaisler I, Schiller D, Weiner I (2000) The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology 23:151-161
44. Shalev U, Weiner I (2001) Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behav Brain Res 126:57-63
45. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463
46. Spear LP, Brake SC (1983) Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16:83-109
47. Spear LP, Shalaby IA, Brick J (1980) Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology 70:47-58
48. Spear NE, Smith GJ (1978) Alleviation of forgetting in preweanling rats. Dev Psychobiol 11:513-529
49. Trimble KM, Bell R, King DJ (1997) Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride. Pharmacol Biochem Behav 56:809-816
50. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
51. Weinberger DR (1995) From neuropathology to neurodevelopment. Lancet 346:552-557
52. Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psych Bull 108:442-461
53. Weiner I (2000) The latent inhibition model of schizophrenia. In: Myslobodsky MS, Weiner I (eds) Contemporary issues in modeling psychopathology. Kluwer Academic, Boston, pp 197-230
54. Weiner I (2001) Latent inhibition. In: Crawley JN, Gerfen CR, Rogawski MA, Sibley DR, Skolnick P, Wray SE (eds) 8.13 Current protocols in neuroscience. Wiley, New York
55. Weiner I (2003) The "two-headed" latent inhibition model of schizophrenia: modeling negative and positive symptoms and their treatment. Psychopharmacology. DOI 10.1007/s002130021313
56. Weiner I, Feldon J (1997) The switching model of latent inhibition: An update of neural substrates. Behav Brain Res 88:11-25
57. Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83:194-199
58. Weiner I, Schnabel I, Lubow RE, Feldon J (1985) The effects of early handling on latent inhibition in male and female rats. Dev Psychobiol 18:291-297
59. Weiner I, Feldon J, Katz Y (1987a) Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacol Biochem Behav 26:241-246
60. Weiner I, Feldon J, Ziv-Harris D (1987b) Early handling and latent inhibition in the conditioned suppression paradigm. Dev Psychobiol 20:233-240
61. Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871-878
62. Weiner I, Shadach E, Tarrasch R, Kidron R, Feldon J (1996) The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biol Psychiatry 40:834-843
63. Weiner I, Shadach E, Barkai R, Feldon J (1997) Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology 16:42-50
64. Weiner I, Schiller D, Gaisler-Salomon I (2003) Disruption and potentiation of latent inhibition by risperidone: The latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology 28:499-509
65. Westbrook RF, Jones ML, Bailey GK, Harris JA (2000) Contextual control over conditioned responding in a latent inhibition paradigm. J Exp Psychol Anim Behav Process 26:157-173
66. Wood GK, Lipska BK, Weinberger DR (1997) Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. Dev Brain Res 101:17-25
67. Young AMJ, Joseph MH, Gray JA (1993) Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience 54:5-9
68. Zuckerman L, Joel D, Weiner I (2001) Nucleus accumbens core lesion produces persistent latent inhibition which is reversed by clozapine but not haloperidol. J Biol Psychiatry 2:S36
69. Zuckerman L, Weiner I (2003) Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology. DOI 10.1007/s00213-003-1461-7